HSP70 activates selective autophagy via UBQLN2 to alleviate hSOD1G93A-mediated neurotoxicity in NSC-34 cellular model of ALS

The human body is a master of recycling. Inside our cells, a constant stream of work breaks down old or damaged proteins and clears them away, making room for new, healthy ones. This cleanup crew relies on two main tools: a system that acts like a shredder for individual proteins, and a larger system called autophagy, which functions like a bulk waste collection truck, grabbing clumps of debris and hauling them to a disposal site. When this system works, cells stay healthy. When it fails, toxic waste piles up, leading to cell death. This breakdown is a central feature of amyotrophic lateral sclerosis, a devastating disease that destroys the nerve cells controlling our muscles. In many cases of this disease, a specific protein called SOD1 mutates, folding into the wrong shape and sticking together in toxic clumps that the cell cannot break down.

Scientists have long known that cells try to fight back against this toxic buildup by producing more of a helper protein called HSP70. Think of HSP70 as a molecular chaperone, a worker that tries to untangle the misfolded proteins or tag them for removal. However, in the disease state, this effort often falls short. The cell seems to have the worker, but it lacks the necessary equipment to actually get the trash to the disposal site. A key piece of this missing equipment is a protein called UBQLN2, which acts as a bridge, connecting the tagged waste to the autophagy collection trucks. The question researchers faced was whether boosting the number of chaperone workers could fix the problem if the bridge itself was broken or missing.

A team of researchers at the Beijing University of Chinese Medicine set out to answer this by building a model of the disease in a dish. They took a line of cells that behave like motor neurons and introduced a mutated version of the SOD1 protein, the kind that causes the disease in humans. As expected, these cells began to struggle. The mutated SOD1 formed toxic clumps, and the cells' ability to clear them away stalled. The researchers observed a classic sign of a blocked waste line: the cells were full of both the collection trucks waiting to leave and the waste waiting to be loaded, meaning the trucks were forming but never arriving at the disposal site. In response to this crisis, the cells naturally tried to help by producing more of the HSP70 chaperone. Yet, despite this increase, the toxic waste remained. At the same time, the researchers noticed that the levels of UBQLN2, the crucial bridge protein, had dropped significantly. The cells had the workers, but the bridge was gone.

To test if the bridge was the missing link, the scientists manipulated the levels of HSP70 in these sick cells. When they forced the cells to produce even more HSP70, the situation improved dramatically. The toxic SOD1 clumps began to disappear, and the waste collection system started moving again. The trucks that had been stuck in traffic finally cleared out, and the toxic waste was degraded. This suggested that having enough chaperone workers could indeed restart the cleanup process. However, the researchers suspected that this success depended entirely on the presence of the bridge. To prove this, they repeated the experiment but this time they removed the UBQLN2 bridge while simultaneously boosting the HSP70 workers. The result was immediate and clear: the cleanup stopped. Even with an abundance of chaperone workers, the toxic waste piled up again, and the collection trucks remained stuck. The system failed completely without the bridge.

The team then looked closer to see how these two proteins interact. Using a method that pulls proteins out of a mixture to see what they are holding onto, they found that HSP70 and UBQLN2 physically bind to each other. When the researchers increased the amount of HSP70, the two proteins held on to each other more tightly, increasing their connection by about half. This physical link appears to be the mechanism that allows the chaperone to hand off the toxic waste to the bridge, which then guides it to the disposal system. The study also ruled out the idea that simply making more waste collection trucks would solve the problem. When they used a drug known to trigger the formation of more trucks, the toxic waste did not clear away effectively. This confirmed that the issue was not a lack of trucks, but a failure in the specific process of loading and delivering the toxic SOD1 waste.

The findings suggest that the disease creates a specific bottleneck where the cell's natural attempt to produce more chaperones is thwarted because the bridge protein is depleted. The researchers propose that the key to fixing this lies in a coordinated approach. Simply adding more chaperones might help, but only if the bridge protein is also present and functional. The study indicates that the relationship between the chaperone and the bridge is a critical hub in the cell's ability to maintain order. If this connection is broken, the cell cannot clear the toxic waste that leads to nerve death. While this work was done in a laboratory model and not in living patients, it provides a clear map of the machinery involved. It points toward a potential strategy where treatments might need to focus on both increasing the helper proteins and ensuring the bridge proteins remain stable, offering a new way to think about how to restore the cell's ability to clean itself.